Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment

por Correll, Christoph U, Schooler, Nina R
Publicado 2020

O4.5. LONG TERM EFFECTS OF EARLY INTERVENTION SERVICES FOR FIRST EPISODE PSYCHOSIS: OUTCOMES OVER FIVE YEARS FROM THE RECOVERY AFTER A 1ST EPISODE OF SCHIZOPHRENIA-EARLY TREATMENT...

por Robinson, Delbert, Schooler, Nina, Kane, John
Publicado 2020

O4.2. THE PREVENTION OF RELAPSE AND HOSPITALIZATION IN FIRST EPISODE AND EARLY PHASE SCHIZOPHRENIA: RESULTS FROM THE PRELAPSE TRIAL

por Kane, John, Robinson, Delbert, Schooler, Nina, Marcy, Patricia, Achtyes, Eric, Correll, Christoph
Publicado 2020

Paliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysis

por Turkoz, Ibrahim, Bossie, Cynthia A, Lindenmayer, Jean-Pierre, Schooler, Nina, Canuso, Carla M
Publicado 2011

O9.7. TECHNOLOGY ASSISTED RELAPSE PREVENTION PROGRAM REDUCES HOSPITALIZATION IN SCHIZOPHRENIA PATIENTS AT HIGH RISK FOR RELAPSE

por Schooler, Nina, Robinson, Delbert, Marcy, Patricia, Homan, Philipp, Achtyes, Eric, Kane, John M
Publicado 2020

Clinical Trials of Potential Cognitive-Enhancing Drugs in Schizophrenia: What Have We Learned So Far?

por Keefe, Richard S. E., Buchanan, Robert W., Marder, Stephen R., Schooler, Nina R., Dugar, Ashish, Zivkov, Milana, Stewart, Michelle
Publicado 2013

T255. WHO PARTICIPATED IN FAMILY WORK IN THE US RAISE-ETP FIRST EPISODE SAMPLE?

por Glynn, Shirley, Gingerich, Susan, Meyer-Kalos, Piper, Mueser, Kim, Chan-Golston, Alec, Sugar, Catherine, Schooler, Nina, Kane, John
Publicado 2018

Paliperidone Palmitate Once-Monthly Injectable Treatment for Acute Exacerbations of Schizoaffective Disorder

por Fu, Dong-Jing, Turkoz, Ibrahim, Simonson, R. Bruce, Walling, David, Schooler, Nina, Lindenmayer, Jean-Pierre, Canuso, Carla, Alphs, Larry
Publicado 2016

F249. FAMILY BURDEN IN THE US RAISE-ETP PROGRAM: TREATMENT EFFECTS AND PREDICTORS

por Glynn, Shirley, Gingerich, Susan, Meyer-Kalos, Piper, Mueser, Kim, Chan-Golston, Alec, Sugar, Catherine, Schooler, Nina, Rosenheck, Robert, Kane, John
Publicado 2018

What Is Causing the Reduced Drug-Placebo Difference in Recent Schizophrenia Clinical Trials and What Can be Done About It?

por Kemp, Aaron S., Schooler, Nina R., Kalali, Amir H., Alphs, Larry, Anand, Ravi, Awad, George, Davidson, Michael, Dubé, Sanjay, Ereshefsky, Larry, Gharabawi, Georges, Leon, Andrew C., Lepine, Jean-Pierre, Potkin, Steven G., Vermeulen, An
Publicado 2010

mHealth for Schizophrenia: Patient Engagement With a Mobile Phone Intervention Following Hospital Discharge

por Ben-Zeev, Dror, Scherer, Emily A, Gottlieb, Jennifer D, Rotondi, Armando J, Brunette, Mary F, Achtyes, Eric D, Mueser, Kim T, Gingerich, Susan, Brenner, Christopher J, Begale, Mark, Mohr, David C, Schooler, Nina, Marcy, Patricia, Robinson, Delbert G, Kane, John M
Publicado 2016